stada arzneimittel-unspn adr
(STDAY:OTC US)
Executive Profile*
Axel MüllerChief Production & Development Officer and Member of the Executive Board, Stada-Arzneimittel AG |
| Age | Total Calculated Compensation | This person is connected to 0 board members in 0 different organizations across 1 different industries. |
| 55 | €1,378,525 As of Fiscal Year 2012 |
Background*
Dr. Axel Müller served as the Chief Production and Development Officer of Stada-Arzneimittel AG since September 16, 2010 and served as its Executive Board Member since 2010. Dr. Müller served as an Exclusive Consultant for numerous international Group projects and periodic assumption of operating management tasks in the STADA Group (since 2005 as Vice President, since 2008 as Senior Vice President), among other things, country responsibility for Switzerland from 1995 ...
Corporate Headquarters*Stadastrasse 2-18Bad Vilbel, -- 61118 Germany Phone: 49 6101 6030 Fax: 49 6101 603 259 Board Members Memberships*There is no Board Members Memberships data available.Education*There is no Education data available.Other Affiliations*There is no Company Affiliations data available. |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| STDAY:US | $0.00 USD | 0.00 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Rajiv De Silva | Chief Executive Officer, President and Director Endo Health Solutions Inc. | -- |
| Louise Makin MA, Ph.D., MBA | Chief Executive Officer and Executive Director BTG plc | 893.0K GBP |
| Erik Bogsch | Managing Director, Member of Executive Board and Director Gedeon Richter Plc. | -- |
| István Hodász | Chief Executive Officer, Managing Director and Director EGIS Pharmaceuticals PLC | -- |
| Said Samih Taleb Darwazah | Chief Executive Officer and Director Hikma Pharmaceuticals plc | $2.0M | Compensation as of Fiscal Year --. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact STADA ARZNEIMITTEL-UNSPN ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
